These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30639259)

  • 1. HTiP: High-Throughput Immunomodulator Phenotypic Screening Platform to Reveal IAP Antagonists as Anti-cancer Immune Enhancers.
    Mo X; Tang C; Niu Q; Ma T; Du Y; Fu H
    Cell Chem Biol; 2019 Mar; 26(3):331-339.e3. PubMed ID: 30639259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
    Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
    Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
    Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
    Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a High-Throughput Gene Expression Screen for Modulators of RAS-MAPK Signaling in a Mutant RAS Cellular Context.
    Severyn B; Nguyen T; Altman MD; Li L; Nagashima K; Naumov GN; Sathyanarayanan S; Cook E; Morris E; Ferrer M; Arthur B; Benita Y; Watters J; Loboda A; Hermes J; Gilliland DG; Cleary MA; Carroll PM; Strack P; Tudor M; Andersen JN
    J Biomol Screen; 2016 Oct; 21(9):989-97. PubMed ID: 27461835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists.
    Beug ST; Conrad DP; Alain T; Korneluk RG; Lacasse EC
    Int J Dev Biol; 2015; 59(1-3):141-7. PubMed ID: 26374535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.
    Perimenis P; Galaris A; Voulgari A; Prassa M; Pintzas A
    BMC Cancer; 2016 Aug; 16():624. PubMed ID: 27520705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-3256336, a novel and orally available small molecule IAP antagonist, induced tumor cell death via induction of systemic TNF alpha production.
    Sumi H; Inazuka M; Hashimoto K; Ishikawa T; Yoshida S; Yabuki M
    Biochem Biophys Res Commun; 2016 Oct; 479(2):179-185. PubMed ID: 27608596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IAP inhibitors enhance co-stimulation to promote tumor immunity.
    Dougan M; Dougan S; Slisz J; Firestone B; Vanneman M; Draganov D; Goyal G; Li W; Neuberg D; Blumberg R; Hacohen N; Porter D; Zawel L; Dranoff G
    J Exp Med; 2010 Sep; 207(10):2195-206. PubMed ID: 20837698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death.
    Selvin T; Berglund M; Lenhammar L; Jarvius M; Nygren P; Fryknäs M; Larsson R; Andersson CR
    BMC Cancer; 2023 Feb; 23(1):164. PubMed ID: 36803614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers.
    Koundinya M; Sudhalter J; Courjaud A; Lionne B; Touyer G; Bonnet L; Menguy I; Schreiber I; Perrault C; Vougier S; Benhamou B; Zhang B; He T; Gao Q; Gee P; Simard D; Castaldi MP; Tomlinson R; Reiling S; Barrague M; Newcombe R; Cao H; Wang Y; Sun F; Murtie J; Munson M; Yang E; Harper D; Bouaboula M; Pollard J; Grepin C; Garcia-Echeverria C; Cheng H; Adrian F; Winter C; Licht S; Cornella-Taracido I; Arrebola R; Morris A
    Cell Chem Biol; 2018 Jun; 25(6):705-717.e11. PubMed ID: 29628435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
    Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
    ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo multiplexed small-molecule screening platform.
    Grüner BM; Schulze CJ; Yang D; Ogasawara D; Dix MM; Rogers ZN; Chuang CH; McFarland CD; Chiou SH; Brown JM; Cravatt BF; Bogyo M; Winslow MM
    Nat Methods; 2016 Oct; 13(10):883-889. PubMed ID: 27617390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.
    Dudgeon DD; Shinde S; Hua Y; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
    J Biomol Screen; 2010 Aug; 15(7):766-82. PubMed ID: 20639499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of apoptosis proteins as intracellular signaling intermediates.
    Kocab AJ; Duckett CS
    FEBS J; 2016 Jan; 283(2):221-31. PubMed ID: 26462035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.
    de Almagro MC; Vucic D
    Exp Oncol; 2012 Oct; 34(3):200-11. PubMed ID: 23070005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of IAP proteins as cancer therapeutics.
    Dynek JN; Vucic D
    Cancer Lett; 2013 May; 332(2):206-14. PubMed ID: 20685035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
    Li L; Thomas RM; Suzuki H; De Brabander JK; Wang X; Harran PG
    Science; 2004 Sep; 305(5689):1471-4. PubMed ID: 15353805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists.
    Asano M; Hashimoto K; Saito B; Shiokawa Z; Sumi H; Yabuki M; Yoshimatsu M; Aoyama K; Hamada T; Morishita N; Dougan DR; Mol CD; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2013 Sep; 21(18):5725-37. PubMed ID: 23928071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of apoptosis (IAP) proteins: novel insights into the cancer-relevant targets for cell death induction.
    Fulda S
    ACS Chem Biol; 2009 Jul; 4(7):499-501. PubMed ID: 19588916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.